Efficacy evaluation stratified by age (ITT).
| Efficacy evaluation | < 60 years (%) | ≥ 60 years (%) | P |
|---|---|---|---|
| n | 47 | 35 | 0.9653 |
| Complete remission | 5 (10.64) | 4 (11.43) | |
| Major response | 18 (38.30) | 15 (42.86) | |
| Minor response | 9 (19.15) | 5 (14.29) | |
| Stable disease | 6 (12.77) | 6 (17.14) | |
| Progressive disease | 6 (12.77) | 4 (11.43) | |
| Not evaluated | 3 (6.38) | 1 (2.86) | |
| Response rate (complete + major + minor) 95% confidence interval (CI) | 32 (68.09) 54.76%-81.41% | 24 (68.57) 953.19%-83.95% |